TGY2IT
HRMY icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Harmony Biosciences HRMY Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125,918
Closed -$4.71M – 454
2025
Q4 		$4.71M Buy
+125,918
New +$4.14M 3.45% 6

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's HRMY Position: Q1 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 125,918 shares — an estimated $4.71M sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in HRMY in Q4 2025 and held it in 1 quarter. The position peaked at $4.71M in Q4 2025. 310 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 125,918 Harmony Biosciences shares in Q1 2026, an estimated $4.71M.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Harmony Biosciences in Q4 2025 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Harmony Biosciences position peaked at $4.71M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q1 2026, filed 7 Aug 2026.